Source: International Congress 2019 – Asthma and the world
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Jansson (Umeå, Sweden), L. Hedman (Luleå, Sweden), C. Stridsman (Umeå, Sweden), M. Axelsson (Malmö, Sweden), H. Katre Kriit (Umeå, Sweden), A. Lindberg (Umeå, Sweden), B. Lundbäck (Gothenburg, Sweden), E. Rönmark (Umeå, Sweden), H. Backman (Umeå, Sweden). Life-years lost due to asthma. 5063

Member's Comments

No comment yet.

Related content which might interest you: Life-years lost due to asthma and COPD Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020 The year in asthma Source: International Congress 2018 – Clinical Year in Review Year: 2018 Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004 Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Living with severe asthma year 2016 Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Benefits of self-management education in COPD exacerbations Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Quality of life in children with asthma associated with allergic rhinitis Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009 The costs of exacerbations in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 273s Year: 2001 Budesonide/formoterol for maintenance and relief in adolescents with asthma: fewer exacerbations and improved asthma control Source: Eur Respir J 2004; 24: Suppl. 48, 164s Year: 2004 An invisible disease: severe asthma is more than just “bad asthma” Source: Eur Respir J, 50 (3) 1701109; 10.1183/13993003.01109-2017 Year: 2017 Could montelukast reduce asthma exacerbations? Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey Source: Eur Respir J 2013; 42: 1224-1233 Year: 2013 Determinants of asthma control and quality of life in stable asthma Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Estimating cost-effectiveness (CE) of seretide in COPD as cost per quality adjusted life year (QALY) Source: Eur Respir J 2004; 24: Suppl. 48, 16s Year: 2004 Quality of life in patients with asthma or rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 120s Year: 2002 Tiotropium improved asthma symptoms and increased time to first exacerbation in patients with moderate-to-severe asthma. Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Costs of COPD and asthma in Sweden Source: Eur Respir J 2004; 24: Suppl. 48, 701s Year: 2004 Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020